Simten Dağdaş

424 total citations
51 papers, 234 citations indexed

About

Simten Dağdaş is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Simten Dağdaş has authored 51 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 26 papers in Genetics and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Simten Dağdaş's work include Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (7 papers). Simten Dağdaş is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Lymphoma Diagnosis and Treatment (9 papers) and Acute Myeloid Leukemia Research (7 papers). Simten Dağdaş collaborates with scholars based in Türkiye, Antigua and Barbuda and Cambodia. Simten Dağdaş's co-authors include Gülsüm Özet, Esragül Akıncı, Mehmet Birhan Yılmaz, S. Eren, Hürrem Bodur, Murat Albayrak, Meltem Aylı, Hüseyin Engin, İshak Özel Tekin and Muhittin A. Serdar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Acta Oncologica and Leukemia Research.

In The Last Decade

Simten Dağdaş

41 papers receiving 227 citations

Peers

Simten Dağdaş
Mustafa Nuri Yenerel Türkiye
G. Tschurtschenthaler Austria
Ayumi Numata Japan
Marguerite Vignon France
Bader Alahmari Saudi Arabia
S. K. China
Monika Trebo Austria
Kiyomi Morita United States
HT Greinix Austria
Bruce Greig United States
Mustafa Nuri Yenerel Türkiye
Simten Dağdaş
Citations per year, relative to Simten Dağdaş Simten Dağdaş (= 1×) peers Mustafa Nuri Yenerel

Countries citing papers authored by Simten Dağdaş

Since Specialization
Citations

This map shows the geographic impact of Simten Dağdaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simten Dağdaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simten Dağdaş more than expected).

Fields of papers citing papers by Simten Dağdaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simten Dağdaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simten Dağdaş. The network helps show where Simten Dağdaş may publish in the future.

Co-authorship network of co-authors of Simten Dağdaş

This figure shows the co-authorship network connecting the top 25 collaborators of Simten Dağdaş. A scholar is included among the top collaborators of Simten Dağdaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simten Dağdaş. Simten Dağdaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dağdaş, Simten, et al.. (2025). Different Presentations and Different Treatment Options in Blastic Plasmacytoid Dendritic Cell Neoplasms: A Case Series. International Journal of Hematology-Oncology and Stem Cell Research. 19(1). 81–85.
2.
Sevindik, Ömür Gökmen, Simten Dağdaş, Leylagül Kaynar, et al.. (2024). Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience. Leukemia Research. 140. 107484–107484. 2 indexed citations
3.
Yiğenoğlu, Tuğçe Nur, Mehmet Ali Erkurt, Simten Dağdaş, et al.. (2024). What is the role of alpha-1 antitrypsin in the management of acute graft versus host disease?. Transfusion and Apheresis Science. 64(1). 104057–104057.
4.
Dağdaş, Simten, et al.. (2024). ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PRESENTING AS STEVENS-JOHNSON SYNDROME (SJS). Hematology Transfusion and Cell Therapy. 46. S32–S33.
5.
Dağdaş, Simten, et al.. (2024). AML-254 What Happened: Suddenly or Acute Abdomen? Difficult Case of ATRARelated Pneumatosis Cystoides Intestinalis. Clinical Lymphoma Myeloma & Leukemia. 24. S302–S302.
6.
Dağdaş, Simten, et al.. (2024). Effectiveness and safety of therapeutic plasma exchange in neurological diseases: An 11‐year report from a tertiary care center. Therapeutic Apheresis and Dialysis. 29(2). 312–320. 1 indexed citations
7.
Özet, Gülsüm, et al.. (2024). MANTLE CELL LYMPHOMA PATIENT WITH SKIN GVHD AFTER AUOTOLOGOUS STEM CELL TRANSPLANT. Hematology Transfusion and Cell Therapy. 46. S31–S32.
8.
Dağdaş, Simten, et al.. (2021). A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry. Hematology Transfusion and Cell Therapy. 45(2). 176–181. 6 indexed citations
9.
Dağdaş, Simten, et al.. (2020). Comparison of allogenic stem cell transplantations performed with frozen or fresh stem cell products with regard to GVHD and mortality. Transfusion and Apheresis Science. 59(4). 102742–102742. 14 indexed citations
10.
Dağdaş, Simten, et al.. (2020). Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE. Indian Journal of Hematology and Blood Transfusion. 37(1). 82–89. 1 indexed citations
11.
Dağdaş, Simten, et al.. (2017). The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma. Turkish Journal of Hematology. 35(2). 94–98. 20 indexed citations
12.
Dağdaş, Simten, et al.. (2017). The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patientsple Myeloma Patients. Turkish Journal of Hematology. 34(3). 226–232. 10 indexed citations
13.
Saydam, Güray, İbrahim C. Haznedaroğlu, Leylagül Kaynar, et al.. (2016). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase. Expert Opinion on Pharmacotherapy. 17(14). 1851–1858. 4 indexed citations
14.
Albayrak, Murat, et al.. (2010). Evaluation of risk factors for thrombophilia in patients with cerebral venous thrombosis. Turkish Journal of Hematology. 27(3). 162–167. 3 indexed citations
15.
Albayrak, Murat, et al.. (2010). Thrombophilic risk factors in women with recurrent abortion. SHILAP Revista de lepidopterología. 1(3). 4 indexed citations
16.
Dağdaş, Simten, Hürrem Bodur, Mehmet Birhan Yılmaz, et al.. (2010). Coagulopathy parameters in patients with Crimean‐Congo hemorrhagic fever and its relation with mortality. Journal of Clinical Laboratory Analysis. 24(3). 163–166. 40 indexed citations
17.
Albayrak, Murat, et al.. (2010). Evaluation of 143 Cases of Immune Thrombocytopenic Purpura With Regards to Clinical Course and Response to Treatment. Eurasian Journal of Medicine. 42(3). 120–123. 1 indexed citations
18.
Albayrak, Murat, et al.. (2009). Risk factors for thrombophilia in young adults presenting with thrombosis. International Journal of Hematology. 90(5). 583–590. 12 indexed citations
19.
Yılmaz, Mehmet Birhan, Simten Dağdaş, Nuran Allı, et al.. (2007). Weber Christian Disease Presenting With Pacytopenia and Anticardiolipin Antibodies. European Journal of Therapeutics. 13(2). 39–41.
20.
Dağdaş, Simten, et al.. (2006). Unusual Extramedullary Hematopoiesis in a Patient Receiving Granulocyte Colony-Stimulating Factor. Acta Haematologica. 116(3). 198–202. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Nuri Yenerel Breakdown of academic impact, for papers by G. Tschurtschenthaler Breakdown of academic impact, for papers by Ayumi Numata Breakdown of academic impact, for papers by Marguerite Vignon Breakdown of academic impact, for papers by Bader Alahmari Breakdown of academic impact, for papers by S. K. Breakdown of academic impact, for papers by Monika Trebo Breakdown of academic impact, for papers by Kiyomi Morita Breakdown of academic impact, for papers by HT Greinix Breakdown of academic impact, for papers by Bruce Greig
Rankless by CCL
2026